Creative Planning
BIB icon

Creative Planning’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Creative Planning’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,735
Closed -$316K – 2061
2018
Q1 		$316K Buy
5,735
+1,433
+33% +$85.8K ﹤0.01% 1319
2017
Q4 		$241K Sell
4,302
-932
-18% -$52.6K ﹤0.01% 1483
2017
Q3 		$321K Buy
5,234
+2,138
+69% +$122K ﹤0.01% 1293
2017
Q2 		$165K Sell
3,096
-710
-19% -$34.6K ﹤0.01% 1635
2017
Q1 		$184K Sell
3,806
-28,484
-88% -$1.32M ﹤0.01% 1543
2016
Q4 		$1.29M Buy
32,290
+256
+0.8% +$10.9K 0.01% 529
2016
Q3 		$1.55M Buy
32,034
+10,400
+48% +$494K 0.01% 451
2016
Q2 		$840K Sell
21,634
-5,025
-19% -$217K 0.01% 569
2016
Q1 		$1.09M Sell
26,659
-9,701
-27% -$429K 0.01% 474
2015
Q4 		$2.6M Buy
36,360
+13,908
+62% +$929K 0.02% 259
2015
Q3 		$1.31M Sell
22,452
-2,454
-10% -$209K 0.01% 405
2015
Q2 		$2.25M Buy
24,906
+21,226
+577% +$1.83M 0.02% 269
2015
Q1 		$291K Sell
3,680
-2,090
-36% -$155K ﹤0.01% 1009
2014
Q4 		$362K Buy
5,770
+4,990
+640% +$293K ﹤0.01% 840
2014
Q3 		$41K Sell
780
-20
-3% -$969 ﹤0.01% 2053
2014
Q2 		$37K Sell
800
-1,660
-67% -$65.5K ﹤0.01% 2078
2014
Q1 		$98K Buy
2,460
+1,540
+167% +$69.9K ﹤0.01% 1409
2013
Q4 		$35K Sell
920
-760
-45% -$25.4K ﹤0.01% 1821
2013
Q3 		$55K Buy
1,680
+880
+110% +$25.5K ﹤0.01% 1452
2013
Q2 		$18K Buy
+800
New +$18.3K ﹤0.01% 1987

Other funds holding BIB

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BA
BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
BRC
Bell Rock Capital Rehoboth Beach, Delaware $81M AUM 9.85% 1-Year Est. Return

Creative Planning's BIB Position: Q2 2018 in Review

Creative Planning sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2018, closing a stake of 5,735 shares — an estimated $316K sold.

Creative Planning first reported a position in BIB in Q2 2013 and held it in 20 quarters. The position peaked at $2.6M in Q4 2015. 38 funds tracked by Wall St. Rank hold BIB as of Q2 2018.

  • Creative Planning reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2018 after selling out during the quarter.
  • Creative Planning sold 5,735 ProShares Ultra NASDAQ Biotechnology shares in Q2 2018, an estimated $316K.
  • Creative Planning first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2013 and held it in 20 quarters.
  • Creative Planning's ProShares Ultra NASDAQ Biotechnology position peaked at $2.6M in Q4 2015.
  • 38 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2018.

Based on Creative Planning's 13F filing for Q2 2018, filed 20 Jul 2018.